You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Diphenoxylate Hydrochloride And Atropine Sulfate patents expire, and what generic alternatives are available?

Diphenoxylate Hydrochloride And Atropine Sulfate is a drug marketed by Hikma, Able, Ani Pharms, Ascot, Bayshore Pharms Llc, Chartwell Rx, Dr Reddys Labs Sa, Fosun Pharma, Heather, Inwood Labs, Kv Pharm, Lannett, Leading, Lederle, Mylan, Parke Davis, Pvt Form, R And S Pharma, Roxane, Specgx Llc, Strides Pharma, Sun Pharm Industries, Upsher Smith Labs, Usl Pharma, Valeant Pharm Intl, Watson Labs, and Winder Labs Llc. and is included in twenty-eight NDAs.

The generic ingredient in DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.

Summary for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
Drug patent expirations by year for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
Recent Clinical Trials for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Puma Biotechnology, Inc.Phase 2
Napo Pharmaceuticals, Inc.Phase 2
University of California, San FranciscoPhase 2

See all DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE clinical trials

Pharmacology for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE

US Patents and Regulatory Information for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Winder Labs Llc DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 211362-001 Jan 27, 2021 AA RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride SOLUTION;ORAL 087708-001 May 3, 1982 RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pvt Form DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 085766-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.